Sign In
Free Newsletter
Johnson & Johnson closes $1.25B Yellow Jersey acquisition
The move allowed the New Brunswick-based pharma giant to secure the global rights to a treatment for atopic dermatitis. Its recent $850 million acquisition of Proteologix Inc. focused on the same area of study.
Cosette acquires Ambien meds from fellow NJ company
U.S. annual sales for the Sanofi-produced prescription sleep aids for the 12 months ended April 2024 were $39 million, according to the Bridgewater-based buyer.
Merck Animal Health closes $1.3B Elanco deal
The Rahway-headquartered buyer will also bring on approximately 280 commercial and manufacturing employees from the Greenfield, Ind.-based company's aqua business.
Cape Regional officially joins Cooper University Health Care
"This agreement will transform health care for the residents and visitors of Cape May and Atlantic counties,” said George Norcross III, chairman of Cooper University Health Care’s board of trustees.
NJBIZ Conversations: Sax Partner Eric Lewandowski
The firm's Transaction Strategy and Transformation leader discusses the state of the mergers and acquisitions market and the outlook for the second half.
Quest completes acquisition of PathAI diagnostics assets
As part of the deal, the Secaucus-based testing provider bought out the company's lab in Memphis and rebranded the facility as AmeriPath.
Cognizant to acquire ER&D firm for $1.3B
The Teaneck-based buyer said joining forces with Belcan LLC will significantly expand its access to the approximately $190 billion engineering research & development services market, among other benefits.
Fisher Porter & Thomas PC merges with the Law Office of Matthew Grabell
The Englewood Cliffs-based boutique law firm said the move will expand its range of legal services to include employment law.
Forvis, Mazars join forces to become top 10 accounting firm
The new "two-firm network" is now a $5 billion global operation and the eighth largest of its kind in the U.S.
Johnson & Johnson completes $13.1B acquisition of Shockwave Medical
The California-based target is known for a first-of-its-kind technology that can be used to treat coronary artery and peripheral artery disease.
Merck to acquire EyeBio in potential $3B deal
The privately held ophthalmology-focused biotechnology company focuses on the treatment of vision loss associated with retinal vascular leakage.
Court approves Cape Regional, Cooper Health merger
Highlights of the union – first unveiled in December 2022 – will include two hospitals with more than 900 licensed beds; revenue exceeding $2.2 billion annually; and nearly 11,000 team members.
